Clinical Trials Browser

Phase 1 × Withdrawn × Glutamine × Clear all

NCT02215083 2017-07-12

L-glutamine Supplementation to Alleviate Symptoms of Taxane-Induced Neuropathy in Patients With Breast Cancer

Phase 1 Withdrawn

Breast Neoplasms, Peripheral Nervous System Diseases